Results 301 to 310 of about 124,423 (315)

Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2009
Charles G Mullighan, Jinghui Zhang, Ina Radtke   +2 more
exaly  

Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia

Cancer Cell, 2016
Christoph Ziegenhain, Michael Dworzak, Christoph Lutz   +2 more
exaly  

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2017
Hagop Kantarjian, Anthony Stein, Nicola Gökbuget   +2 more
exaly  

Treatment of Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2006
Ching-Hon Pui, William E Evans, Pui Ching-Hon   +2 more
exaly  

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

New England Journal of Medicine, 2020
Robin Foa, Renato Bassan, Antonella Vitale   +2 more
exaly  

Priapism in acute lymphoblastic leukemia

Cancer, 1972
V V, Vadakan, J, Ortega
openaire   +2 more sources

Blinatumomab for Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2017
Hagop, Kantarjian, Elias, Jabbour, Max S, Topp   +2 more
openaire   +3 more sources

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

New England Journal of Medicine, 2018
Jae H Park, Mithat Gonen, Craig S Sauter   +2 more
exaly  

Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia

Cancer Cell, 2018
Duohui Jing, Yizhou Huang, Chelsea Mayoh   +2 more
exaly  

Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

Annals of Oncology, 2008
M Wetzler
exaly